Investors & Media International Stem Cell Corporation Announces $25 Million Common Stock Financing Agreement International Stem Cell Corporation Announces Commercial Sales to General Public of Its Breakthrough Stem Cell-Based Lines of Skin Care Products International Stem Cell Corporation Announces the Commercial Launch of Its Breakthrough Stem Cell-Based Line of Skin Care Products Heightened Interest from the Medical Research Community and New Funding of International Stem Cell Corporation's (ISCO) Therapeutic Research International Stem Cell Corporation Announces Completion of Its First Manufacturing Run of Lifeline Skin Care's Stem Cell-Based Skin Rejuvenation Products International Stem Cell Corporation Announces Launch Plans for New Skin Care Products ISCO to Present Data on Progress of Human Parthenogenetic Stem Cell Differentiation into Functional Liver Cells at the Annual Meeting of the American Association for the Study of Liver Diseases International Stem Cell Corporation and Insight Bioventures India Structure Indian Affiliate to Develop Stem Cell-Based Eye Care Therapeutics for India and Produce Research Products for Asia International Stem Cell Corporation Announces Significant Progress Towards Creation of the First Bank of Immune-Matched Human Parthenogenetic Stem Cells International Stem Cell Corporation Not Adversely Affected by Stem Cell Research Funding Ban 20 21 22 23 24 25 26 27 28 29 30 << < > >>
